BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2663537)

  • 1. [The role of muscarinic cholinoreceptors in regulating cellular functional activity].
    Dolgo-Saburov VB
    Farmakol Toksikol; 1989; 52(2):100-5. PubMed ID: 2663537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic potentiation of excitatory amino acid-evoked dopamine release in mesencephalic cells: specificity for the NMDA response and role of intracellular messengers.
    Allaoua H; Chaudieu I; Alonso R; Quirion R; Boksa P
    Synapse; 1993 Sep; 15(1):39-47. PubMed ID: 8310424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current concepts of the functional characteristics of the muscarinic cholinoceptor].
    Dolgo-Saburov VB
    Farmakol Toksikol; 1985; 48(6):5-10. PubMed ID: 3936730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of muscarinic receptors, G-proteins, and intracellular messengers in muscarinic modulation of NMDA receptor-mediated synaptic transmission.
    Aramakis VB; Bandrowski AE; Ashe JH
    Synapse; 1999 Jun; 32(4):262-75. PubMed ID: 10332802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic mechanisms of antipsychotic atypicality.
    Bymaster FP; Felder CC; Tzavara E; Nomikos GG; Calligaro DO; Mckinzie DL
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1125-43. PubMed ID: 14642972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic toxins: tools for the study of the pharmacological and functional properties of muscarinic receptors.
    Servent D; Fruchart-Gaillard C
    J Neurochem; 2009 Jun; 109(5):1193-202. PubMed ID: 19457160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists.
    Wang SZ; el-Fakahany EE
    J Pharmacol Exp Ther; 1993 Jul; 266(1):237-43. PubMed ID: 7687290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.
    Tejada FR; Nagy PI; Xu M; Wu C; Katz T; Dorsey J; Rieman M; Lawlor E; Warrier M; Messer WS
    J Med Chem; 2006 Dec; 49(25):7518-31. PubMed ID: 17149881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective effector coupling of muscarinic acetylcholine receptor subtypes.
    Fukuda K; Kubo T; Maeda A; Akiba I; Bujo H; Nakai J; Mishina M; Higashida H; Neher E; Marty A
    Trends Pharmacol Sci; 1989 Dec; Suppl():4-10. PubMed ID: 2694521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]propylbenzilylcholine mustard-labeling of muscarinic cholinergic receptors that selectively couple to phospholipase C or adenylate cyclase in two cultured cell lines.
    Liang M; Martin MW; Harden TK
    Mol Pharmacol; 1987 Oct; 32(4):443-9. PubMed ID: 3118180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic receptor-mediated nitric oxide release in a K562 erythroleukaemia cell line.
    Cabadak H; Küçükibrahimoğlu E; Aydin B; Kan B; Zafer Gören M
    Auton Autacoid Pharmacol; 2009 Jul; 29(3):109-15. PubMed ID: 19364336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of M- and N-cholinoreceptors in regulating the metabolism of the pyrimidine nucleotides of RNA in digestive glands].
    Shostakovskaia IV; Dubitskiĭ LA
    Fiziol Zh (1978); 1985; 31(5):624-8. PubMed ID: 2414137
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.
    Messer WS; Abuh YF; Liu Y; Periyasamy S; Ngur DO; Edgar MA; El-Assadi AA; Sbeih S; Dunbar PG; Roknich S; Rho T; Fang Z; Ojo B; Zhang H; Huzl JJ; Nagy PI
    J Med Chem; 1997 Apr; 40(8):1230-46. PubMed ID: 9111297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenoxybenzamine and benextramine, but not 4-diphenylacetoxy-N-[2-chloroethyl]piperidine hydrochloride, display irreversible noncompetitive antagonism at G protein-coupled receptors.
    Bodenstein J; Venter DP; Brink CB
    J Pharmacol Exp Ther; 2005 Aug; 314(2):891-905. PubMed ID: 15857948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cyclic AMP metabolism by muscarinic cholinergic receptors.
    Harden TK; Evans T; Hepler JR; Hughes AR; Martin MW; Meeker RB; Smith MM; Tanner LI
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1985; 19():207-20. PubMed ID: 2988297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
    Lee NH; Geoghagen NS; Cheng E; Cline RT; Fraser CM
    Mol Pharmacol; 1996 Jul; 50(1):140-8. PubMed ID: 8700106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of the muscarinic receptors in the pathogenesis of the convulsive state induced by korazol in rats].
    Khobotova ZI; Mukovskiĭ LA; Kosmachev AB; Fil'ko OA; Filippov VN; Dolgo-Saburov VB
    Eksp Klin Farmakol; 1997; 60(1):16-8. PubMed ID: 9162273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of cellular excitability in neocortex: muscarinic receptor and second messenger-mediated actions of acetylcholine.
    Cox CL; Metherate R; Ashe JH
    Synapse; 1994 Feb; 16(2):123-36. PubMed ID: 7910986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of adenylate cyclase and phosphoinositide second messenger systems in regulation of acetylcholine secretion in synapses of the cerebral hemispheres and brain stem in rats].
    Kosmachev AB; Fil'ko OA; Dolgo-Saburov VB; Filippov VN; Podosinovikova NP; Solov'eva NE
    Eksp Klin Farmakol; 1997; 60(6):3-6. PubMed ID: 9460586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docking analyses on human muscarinic receptors: unveiling the subtypes peculiarities in agonists binding.
    Vistoli G; Pedretti A; Dei S; Scapecchi S; Marconi C; Romanelli MN
    Bioorg Med Chem; 2008 Mar; 16(6):3049-58. PubMed ID: 18182302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.